Results per Page:
The benefits of HIV research? Let us count the ways
HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
‘Action and progress link our globe’
HVTN’s Dr. Daniel Driffin focused on hope in remarks at White House World AIDS Day event
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor.
'Cautiously optimistic about HIV vaccines'
A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
New HIV vaccine study launched for World AIDS Day
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Insights from infants could inform HIV vaccine design
Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV
Enlisting the microbiome in the quest for an AIDS vaccine
We now know that microbial communities, especially in our guts, profoundly affect immune response
Understanding HIV’s evolutionary past — and future
Studies of how the virus evolved and how it might change down the road could help researchers develop vaccines or cures for the infection
On World AIDS Day, renewed hope for an HIV vaccine
Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’
Super survivors: What those with HIV who don't get sick can teach us
Meet five ‘HIV controllers,’ some positive for decades, who may hold clues to ending AIDS
Countdown to Zero: The path to an HIV vaccine
A World AIDS Day Q&A with Fred Hutch’s Dr. Larry Corey, featured in HBO special report